| 000 | 01872 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515100353.0 | ||
| 264 | 0 | _c20080306 | |
| 008 | 200803s 0 0 eng d | ||
| 022 | _a0835-7900 | ||
| 024 | 7 |
_a10.1155/2007/203201 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMorgan, D G | |
| 245 | 0 | 0 |
_aMaintenance treatment of gastroesophageal reflux disease: an evaluation of continuous and on-demand therapy with rabeprazole 20 mg. _h[electronic resource] |
| 260 |
_bCanadian journal of gastroenterology = Journal canadien de gastroenterologie _cDec 2007 |
||
| 300 |
_a820-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a2-Pyridinylmethylsulfinylbenzimidazoles _xadministration & dosage |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGastroesophageal Reflux _xcomplications |
| 650 | 0 | 4 |
_aHeartburn _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProton-Translocating ATPases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRabeprazole |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aO'Mahony, M F J | |
| 700 | 1 | _aO'Mahony, W F | |
| 700 | 1 | _aRoy, J | |
| 700 | 1 | _aCamacho, F | |
| 700 | 1 | _aDinniwell, J | |
| 700 | 1 | _aHorbay, G L A | |
| 700 | 1 | _aHusein-Bhabha, F A | |
| 773 | 0 |
_tCanadian journal of gastroenterology = Journal canadien de gastroenterologie _gvol. 21 _gno. 12 _gp. 820-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1155/2007/203201 _zAvailable from publisher's website |
| 999 |
_c17593270 _d17593270 |
||